Several studies have reported that a lower serum ALB value was linked to a shorter DFS and OS in a variety of cancers, however, only a few studies have focused on the clinical impact on the level of serum albumin in head and neck cancer patients (13, 18–20). This evidence concerns the gene ALB and cancer.